On August 6, Aflac (NYSE:AFL) reported second-quarter numbers that point in opposite directions. Net earnings climbed to $825 million, helped along by investment losses that shrank to $153 million from $421 million a year ago. Adjusted earnings, though, fell 7.7% to $883 million. Both numbers are real, but they answer different questions. Which measure you trust changes the story, so here is what sits underneath.
Start with the yen, because it is muddying the picture. The average rate was 159.45 to the dollar, 9.3% weaker than a year earlier, and that cost adjusted earnings $0.05 a share. Take the currency out of the first half and adjusted earnings per share rose 4.1% to $3.57. ******* an is also running more profitably. Its pretax adjusted margin widened to 34.3% from 32.0% as claims took a smaller bite out of premiums, and yen-based pretax adjusted earnings rose 3.4%. So part of the decline in ******* an's dollar-reported profit is currency, not operations.
The US business is still growing at the top line. Net earned premiums rose 2.3% to $1.5 billion, and sales climbed 2.6% to $349 million, led by group voluntary benefits along with dental and vision plans. In ******* an, the refreshed Tsumitasu life policy and the new Anshin Palette medical product grew strongly in the quarter, and first-half sales rose 7.0% to ¥37.3 billion. Then there is the cash. Aflac returned $1.3 billion to shareholders in the quarter, $983 million of it through buybacks, and declared a $0.61 third-quarter dividend, payable September 1 to holders of record on August 19, 2026. Management notes 43 straight years of dividend increases through 2025 and says the board is on a path to extend that in 2026.
The catch is that ******* an's profit gains came from lower claims, not a bigger business. Net earned premiums in yen fell 3.7%, mainly because of a new external reinsurance deal and older limited-pay policies reaching paid-up status. Premium persistency, the share of policies customers keep, slipped to 92.7% from 93.7%. ******* an's pretax adjusted earnings still fell 2.1% once currency is stripped out, and new sales dipped 5.6% in the quarter against a tough comparison for the Miraito cancer product, which launched in March 2025.
The US segment has its own soft spot. Pretax adjusted earnings fell 4.6% to $370 million, and the margin narrowed to 20.9% from 22.5% as claims and benefits took a bigger share of premiums. Corporate and Other swung to a $10 million pretax adjusted loss from a $20 million gain a year earlier, with interest expense up 21.6% to $62 million. And adjusted book value per share, excluding foreign currency remeasurement, slid to $41.22 at June 30 from $42.97 a year earlier.

#earnings #fell

On September 3, 2026, lululemon athletica inc. (NASDAQ:LULU) reported second-quarter fiscal 2026 results for the period ended August 2, 2026. Net revenue fell 4% to $2.4 billion, missing the $2.46 billion ****** ysts expected, and comparable sales dropped 10% on a constant dollar basis. Management cut full-year revenue guidance to a decline of 5% to 7%, down from a prior forecast of flat to down 1%, and lowered full-year earnings per share guidance to $9.48 to $9.73 from its prior forecast of $10.95 to $11.15, compared with $13.26 earned in fiscal 2025. Shares fell about 18% in extended trading. Incoming CEO Heidi O'Neill was set to start the following week.
Photo by Ian Deng Quddu on Unsplash
Citi's cut to $117 from $130 came with a Neutral rating and the observation that the stock's risk-reward is "slightly more favorable" after the selloff, even though the firm called fiscal 2027 visibility "very unclear." The operational bright spots are real.
lululemon athletica inc. (NASDAQ:LULU) increased its chase volume, the supply chain capability that lets it reorder fast-moving styles quickly, by about 20% this year, and away-from-body styles including the Groove Wide-Leg, Align Foldover Jogger, Breezily, and an updated Dance Studio Pant are trending well as shoppers shift from tight-fitting leggings. The brand's community pull held up too.
The SeaWheeze Half Marathon and Festival returned in August for the first time since 2019, drawing nearly 10,000 runners from 24 countries and roughly 14,000 festival attendees, while more than 85,000 people from 120 countries joined the companion Strava challenge, strong enough that Lululemon already committed to bringing the event back next summer. Rest of World revenue, spanning EMEA and APAC, grew 5% on a reported basis, and the company ended the quarter with $1.4 billion in cash and no outstanding borrowings.

#revenue #billion #NASDAQ

(NEXSTAR) – The days getting shorter serve as a reminder that we’re barreling toward the end of our seasonal observation of daylight saving time, but the wheels may be in motion to stop that – a move more than a dozen states have been waiting to happen.
Earlier this year, the House passed the Sunshine Protection Act, which would make daylight saving time permanent throughout the U.S., with few exceptions. It’s been held up in the Senate since July but, now that the chamber has returned from recess, there’s a chance the legislation could be picked up.
If it can pass the Senate, the bill seems to stand a fair chance of becoming law, with President Trump already expressing support.
For more than a dozen states, this is the closest they’ve been in years to seeing some of their own legislation finally take effect. The U.S. hasn’t been this close to permanent daylight saving time since a version of the Sunshine Protection Act passed in the Senate in 2022 but fizzled in the House.
At present, states are only allowed to opt into year-round permanent standard time, as Hawaii and much of Arizona have done. But that hasn’t stopped 19 states from enacting legislation that would make daylight saving time permanent in their jurisdiction, pending approval from Congress.

#House

Nvidia (NVDA) CEO Jensen Huang is challenging the people warning that AI could end humanity, suggesting their alarming predictions may serve another purpose.
Speaking with CBS News, Huang rejected the 'AI apocalypse' debate and questioned the motives behind those spreading that fear, adding a sharper edge to an increasingly public industry split.
OpenAI and Anthropic leaders, alongside Elon Musk, have backed calls to slow advanced AI development over safety concerns and fears that the technology might be advancing quicker than companies can control it, as reported by Financial Times.
For Nvidia investors, that debate carries financial weight. Shares have returned 20% year-to-date and 23% over the six months, according to Seeking Alpha data.
A coordinated slowdown could complicate the spending boom supporting its chip business. Huang's response, however, reaches beyond defending continued investment.

#NVIDIA #anthropic

On September 17, Ferrari N.V. (NYSE:RACE) announced a partnership with the technology company Rakuten Group, Inc., effective January 1, 2027. The announcement gives no scope and no price tag, so it works better as a signal than as a number. The real substance sits in the results Ferrari posted on July 30, when it raised its 2026 guidance because buyers are ordering more personalization than the company expected.
In the second quarter, revenue rose 8%, but operating profit rose 10%, which means each euro of sales is leaving more behind. Ferrari credits a richer mix of cars, with the F80 helping, along with more buyers paying up for personalization. Strip out currency swings, and the gap widens, with revenue up 11% and operating profit up 16%. Deliveries of the Purosangue and the 296 Speciale family grew even in the middle of a planned model changeover.
Cash and demand back that up. Industrial free cash flow jumped 39% to €276 million, and Ferrari also returned more than €800 million to shareholders through a dividend and buybacks. Racing helped too, as higher sponsorships and engine rentals to other Formula 1 teams lifted revenue. Meanwhile, the order book covers 2027 in full, and the new 12Cilindri Manuale is already fully allocated, which is about as strong a demand signal as a carmaker can send. Those trends are why revenue guidance moved up to about €7.60 billion from about €7.50 billion.
Part of the strength is timing. Operating profit got a boost from temporarily lower depreciation and amortization while Ferrari swaps out models, and the company says those charges will climb once the new cars enter production. Net profit also leaned on a 23.0% tax rate, which reflects an estimated benefit from the new Patent Box. Neither says much about how profitable the cars themselves are.
Costs are climbing too. Higher industrial and marketing expenses weighed on operating profit, EBITDA margin slipped to 39.0% from 39.7% a year earlier, and management expects heavier brand, racing and digital spending for the year. Currency is a drag as well, mostly from the dollar and the yen, which is why 11% growth at constant currency shrank to 8% as reported. Deliveries totaled 3,366 cars while the 296 GTS, Roma Spider and SF90 XX family wound down, and sponsorship, commercial and brand revenue grew just 2%. And the whole outlook leans on current visibility into the Middle East crisis, which Ferrari cannot control.

#Ferrari

On August 6, Republic Services (NYSE:RSG) reported earnings of $1.84 per diluted share for the quarter that closed on June 30, up from $1.75 a year earlier, and lifted most of its full-year targets. Here is the odd part. The company moved less volume than it did a year ago and still grew profit. Understanding how that works, and how long it can last, is the whole story.
Start with pricing, because that is the engine. Core price on total revenue added 5.3% to growth, which helped lift total revenue by 4.6%. Inside the related business, price contributed 4.1% in the restricted portion and 7.8% in the open market. Management says price beat cost inflation, and the margin backs that up. Adjusted EBITDA reached $1.42 billion at a 32.1% margin, matching the prior year even after Republic absorbed a 50 basis point drag from event-driven landfill volumes it received in 2025.
Cash generation is just as sturdy. Through the first half of 2026, operations produced $2.38 billion, and adjusted free cash flow came to $1.58 billion. That paid for $860 million of acquisitions and $1.04 billion returned to shareholders, so Republic is buying growth and rewarding owners from the same pool. The board added 4.5 cents to the quarterly dividend, setting it at $0.670 per share with an October 2 record date and payment on October 15. Management also raised full-year revenue, adjusted EBITDA, and free cash flow guidance, and set adjusted earnings at $7.23 to $7.28 per share.
The catch is that volume is moving the wrong way. Average yield added 3.4% to total revenue, while volume took away 1.6%, and the related business gave up 1.9% to volume. That makes this a price-led story, and price can only carry so much weight if volumes keep shrinking. Acquisitions also supplied 1.1% of the 4.6% total growth, so organic growth is smaller than the headline suggests.
Other lines were softer too. The environmental solutions business slipped 0.2%, so it added no lift. Recycled commodities sold for an average of $136 per ton at Republic's recycling centers, which is $13 lower than a year earlier. Margin only matched last year's level, and adjusted earnings per share rose 4.5%, just under revenue growth, so profit grew in step with sales rather than faster.

#year

If you're trying to choose between the Vanguard S&P 500 ETF (NYSEMKT: VOO) and the State Street SPDR S&P 500 ETF (NYSEMKT: SPY), it might seem they're essentially interchangeable. They're both huge and track the same index.
At a high level, that's probably true. But if you want to dive deep and get picky, a few factors set them apart.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
The State Street SPDR S&P 500 ETF has an expense ratio of 0.0945%. The Vanguard S&P 500 ETF charges just 0.03%. Given that the index has historically returned about 10% per year, this fee difference may seem immaterial. But I will take any advantage I can get.
Because of their sizes, trading spreads (the difference between the buying (ask) price and the selling (bid) price of a stock) are virtually nothing, so spreads aren't really a consideration here. But if you can own the exact same index for a third of the cost, why not?

#index #same

Automattic has a new interim chief financial officer: Jeremy Klaperman, the CFO of the company's WordPress VIP Enterprise business unit. The news, shared internally on Friday, follows last week's attempted ouster of Automattic CEO Matt Mullenweg, which ultimately resulted in the departure of the board members who voted him out and other executives, including then-CFO Mark Davies. Davies was briefly interim CEO before Mullenweg retook the position.
In a Slack post, Mullenweg shared that Klaperman had previously acted as Automattic CFO when Davies had been on sabbatical. He noted that the board — whose new members have yet to be announced — will still need to evaluate internal and external candidates for the position before a final decision is made.
In addition, Mullenweg said in the post that a candidate to become the company's chief legal officer had also just verbally accepted the position, replacing Chief Legal Officer Andy Missan, who has also since left the company alongside Davies. TechCrunch recently reported that Davies and Missan had signed reciprocal severance deals during Mullenweg's 33-hour leave of absence before he returned as CEO.
"I have 100% confidence in our cash and financial position," Mullenweg's post concluded, adding "There is still work to do, but everything is within our control and depends only on Automattic's ability to execute."
In subsequent updates, Mullenweg also said to "stay tuned" for board announcements, and noted that special advisor and creator of Wolfram|Alpha, Stephen Wolfram, will continue in his position. The company's next board meeting is scheduled for September 23.

#klaperman

Johnson & Johnson (JNJ) stock has returned about 57% over the past year, against about 17% for the S&P 500. On the earnings it has already banked, that price looks expensive. But those earnings carry STELARA, which is losing share to biosimilar competition. What looks dear on earnings already reported comes down sharply on the earnings ***** ysts expect.
At about $270 a share, Johnson & Johnson trades at about 28.3 times its trailing earnings. That figure sits on adjusted earnings: normalized net income with stock-based compensation added back, meant to sit closer to the basis ***** ysts use in their forecasts than a GAAP figure would, though the two measures are not defined identically. Measured as market value against consensus net income, the multiple on fiscal 2026 earnings is about 24.1 times, and on the earnings expected for 2027 it is about 20.9 times.
Those trailing twelve months were not a clean run. STELARA cost Johnson & Johnson about 460 basis points of operational sales growth in the second quarter of 2026. Strip it out and the company grew double digits in that quarter on the same basis, on management's own account.
The trailing multiple measures today's price against a period burdened by slowing STELARA revenue. The rest of the portfolio kept growing. Revenue over the trailing twelve months is close to $98 billion, and the company has 28 products and platforms that each sell more than $1 billion a year.
Immunology shows both sides at once. TREMFYA grew 71% in the second quarter of 2026, and it remains the fastest-growing advanced therapy in both Crohn's disease and ulcerative colitis. STELARA is shrinking under biosimilars in that same segment.

#johnson #earnings

One of the world's largest companies has become a cash-return machine of historic scale, but its engine is now facing a serious test.
With Apple (AAPL) stock trading near $337 a share, an owner might ask a simple question. The company has returned a fortune in cash while the stock has dramatically outperformed the market; was holding worth it, and can this machine keep running?
Over the last five years, Apple sent $510.4 billion in cash back to its shareholders. That sum, equal to about 10.3% of the company's current market value, is the largest capital return of any U.S. company Trefis tracks over that period. The question is what that extraordinary payout says about the business today.
The money printer is Apple's core business, which generated $136.68 billion in free cash flow over the last twelve months. In its most recent quarter, the company reported record June-quarter revenue, with iPhone sales growing 22% and Mac sales growing an impressive 29% from a year ago. Management noted that the iPhone and Mac were "both doing remarkably better than we thought they would do."
That operational strength funds the shareholder returns. The five-year payout was heavily weighted toward share repurchases, which totaled $434.5 billion, with another $75.9 billion paid in dividends. Apple's absolute dollar payout stands alone, even though the 10.3% of market value it returned sits well below the 16.9% median for S&P 500 companies.

#market

Merck (MRK) stock returned about 87% over the past twelve months, climbing from roughly $79 to about $147. Nothing in the year's results looks like that. The medicines Merck sells today grew at their usual pace. Investors spent the year repricing what comes next.
Revenue over the trailing twelve months was $66.6 billion, up 4.6% and in line with its own three-year pace. Profitability did not follow. Its operating margin over the same twelve months was 10.5%, versus a three-year average of 22.4%.
Most of that gap is one purchase. Merck took a $5.7 billion charge in the second quarter of 2026, about 9% of a year's sales. It bought Terns Pharmaceuticals, and with it MK-4208, a candidate for chronic myeloid leukemia. The bill hits earnings now and the medicine arrives later.
The proof matters because of the risk hanging over this stock. The KEYTRUDA family was just over half of Merck's revenue in the second quarter of 2026. The company is openly planning for the end of that exclusivity when Keytruda loses primary U.S. patent protection in 2028. Management describes the stretch as more of a hill than a cliff, with a shallow dip and a fast return to growth.
Johnson & Johnson (JNJ) returned 56% over the same twelve months and Pfizer (PFE) 23%, so a good year for pharmaceuticals explains some of this but not Merck's lead. What separated Merck was evidence. The FDA approved LIPFENDRA, the first and only oral PCSK9 inhibitor. In the CORALreef Lipids trial it lowered LDL cholesterol by up to 60% when added to a statin.

#year #johnson

On September 18, Prudential Financial (NYSE:PRU) announced it will sell every share it holds in Alexforbes, a company listed on the Johannesburg Stock Exchange. Two buyers are splitting the stake. Alexforbes will repurchase roughly 372.8 million shares itself, and ARC AF Holdings will take about 74.1 million more. The package is worth about $185 million, a small number for a company managing $1.642 trillion. But the message matters more than the money. A plan Prudential laid out in August is now turning into signed agreements.
The logic is easy to follow. Prudential wants to operate in fewer places and put its money, people and attention where it thinks it can win for years. Andy Sullivan, the chief executive, says the aim is to lean harder on ***** et management, retirement and protection, and get those units working together more closely. David Legher, who leads emerging markets, called Alexforbes a successful investment, so this reads as a planned exit rather than a retreat from a problem.
The core business is giving management room to be choosy. On August 4, Prudential reported second-quarter net income of $985 million, up from $533 million a year earlier. That happened even though a charge from the yearly ***** umption update grew to $299 million from $134 million, so the underlying engine ran strong enough to absorb a bigger hit. The company also returned $743 million to shareholders in the quarter and held $4.2 billion in highly liquid ***** ets at the parent level. That does not look like a seller in a hurry.
Start with what has not happened yet. The deals are expected to close in the first half of 2027, and they still need Alexforbes shareholders to approve the buyback, along with regulatory sign-off. Until then, $185 million is an agreed price, not cash in the bank. Prudential also said New Veld's involvement continues before completion, so the company stays tied to the ***** et for now.
Then there is the size. Set against those trillions in ***** ets, this sale will not move results either way. Its value is strategic, and strategy takes years to judge. Prudential is giving up a foothold in a partnership it called important, and its remaining businesses have their own snags. Sales in Prudential of ***** an are suspended, and management said that weighed on international results even as earnings held up.

#august #money

On August 10, Ferguson Enterprises Inc. (NYSE:FERG) reported results for the quarter ended June 30, and the numbers show a company growing straight through a soft housing market. Sales rose 4.6% to $8.8 billion, and management lifted its outlook for the full year. But profit grew more slowly than sales, and that gap is what makes this report worth a closer look.
The strongest engine was non-residential work, where US revenue jumped 8% on share gains in what management called a mixed market. Large capital projects are part of the story, with open order volumes growing and bidding activity strong, so there is a pipeline behind the current numbers. Housing, roughly half of revenue, is the weak spot. Yet residential sales still rose 2% in the US even though new construction is weak and repair work is soft, which means Ferguson is beating its markets rather than riding them.
Capital deployment is the second pillar. Ferguson closed five acquisitions in the quarter, and on July 13, it announced a deal for FWI Holdings, known as FloWorks, an industrial distributor of valves and flow-control products that is expected to close in the third quarter. The eight deals announced this year carry about $1.4 billion in annualized revenue, a second growth path alongside organic sales. Net debt sits at 1.3 times adjusted EBITDA, a level management calls strong. The company also returned cash, buying back $202 million of stock in the quarter and declaring a $0.89 dividend payable October 7 to holders of record on August 21. Management raised its full-year sales outlook to mid-single-digit growth, before counting FloWorks.
Start with the gap between sales and profit. Adjusted operating profit rose 2.9%, behind the 4.6% sales gain, and gross margin slipped 20 basis points to 31.0%. Ferguson notes that last year's gross margin was temporarily lifted by the timing of supplier price increases, which is fair context, but the direction is still down. Reported earnings per share of $3.43 rose 6.9%, while the adjusted figure of $3.39 grew a slower 5.3%.
Then there are the soft spots. About half of revenue comes from residential markets that management describes as subdued, so a 2% gain there is modest. Canada's sales slipped 1.9%, with a business divestment outweighing organic growth, and management calls the market there challenging, especially in residential. Management also describes the economic environment as uncertain, and the margin part of the guidance raise is small. The low end of the adjusted operating margin range moved from 9.4% to 9.5%, while the top stayed at 9.8%. The guidance also leaves out FloWorks, and net debt to adjusted EBITDA is 1.3 times, against 1.2 times a year ago.

#management

The idea of building a $1 million portfolio might sound more daunting than climbing Mt. Everest. In reality, it's more achievable than you probably think. With enough time, discipline, and the right mix of investments, the long-term power of compounding can get you to the $1 million mark and beyond!
Just take a look at history. If you invested $10,000 in the S&P 500 (SNPINDEX: ^GSPC) at the beginning of 1996, it would have grown to roughly $214,000 with dividends reinvested. Now, that's clearly not $1 million, but that's how large it grew with a one-time investment. Imagine how big it could get if you added a modest monthly investment to it over all those years.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our ****** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
This is why the idea of regular, consistent investing over time is one of the best pathways to millionaire status.
Over the past century, the S&P 500 has returned around 10% annually. The index has performed much better than that over the past decade, but the next decade could very well be much worse. When projecting long-term returns, it's better to be a little more conservative.

#idea #investment #past

On August 6, Aflac (NYSE:AFL) reported second-quarter numbers that point in opposite directions. Net earnings climbed to $825 million, helped along by investment losses that shrank to $153 million from $421 million a year ago. Adjusted earnings, though, fell 7.7% to $883 million. Both numbers are real, but they answer different questions. Which measure you trust changes the story, so here is what sits underneath.
Start with the yen, because it is muddying the picture. The average rate was 159.45 to the dollar, 9.3% weaker than a year earlier, and that cost adjusted earnings $0.05 a share. Take the currency out of the first half and adjusted earnings per share rose 4.1% to $3.57. **** an is also running more profitably. Its pretax adjusted margin widened to 34.3% from 32.0% as claims took a smaller bite out of premiums, and yen-based pretax adjusted earnings rose 3.4%. So part of the decline in **** an's dollar-reported profit is currency, not operations.
The US business is still growing at the top line. Net earned premiums rose 2.3% to $1.5 billion, and sales climbed 2.6% to $349 million, led by group voluntary benefits along with dental and vision plans. In **** an, the refreshed Tsumitasu life policy and the new Anshin Palette medical product grew strongly in the quarter, and first-half sales rose 7.0% to ¥37.3 billion. Then there is the cash. Aflac returned $1.3 billion to shareholders in the quarter, $983 million of it through buybacks, and declared a $0.61 third-quarter dividend, payable September 1 to holders of record on August 19, 2026. Management notes 43 straight years of dividend increases through 2025 and says the board is on a path to extend that in 2026.
The catch is that **** an's profit gains came from lower claims, not a bigger business. Net earned premiums in yen fell 3.7%, mainly because of a new external reinsurance deal and older limited-pay policies reaching paid-up status. Premium persistency, the share of policies customers keep, slipped to 92.7% from 93.7%. **** an's pretax adjusted earnings still fell 2.1% once currency is stripped out, and new sales dipped 5.6% in the quarter against a tough comparison for the Miraito cancer product, which launched in March 2025.
The US segment has its own soft spot. Pretax adjusted earnings fell 4.6% to $370 million, and the margin narrowed to 20.9% from 22.5% as claims and benefits took a bigger share of premiums. Corporate and Other swung to a $10 million pretax adjusted loss from a $20 million gain a year earlier, with interest expense up 21.6% to $62 million. And adjusted book value per share, excluding foreign currency remeasurement, slid to $41.22 at June 30 from $42.97 a year earlier.

#adjusted #pretax

BuyWander says it plan to use the fresh capital to drive its expansion throughout the US, support technological upgrades, and bolster its executive team.
The investment was headed by Madrona Venture Group and Inspired Capital. Past supporters of the company include Triple Impact Capital, Silence Ventures, Animal Capital, as well as several angel investors.
The business currently has eight locations and has lately entered the Denver and Chicago markets, with a new warehouse site scheduled to open soon in Minneapolis.
BuyWander co-founder and CEO Jordan Allen said: "Retailers are sitting on billions of dollars in returned and overstocked inventory every year, and buyers are hungry for a better way to access it. We've seen that appetite play out in every market we've entered. This funding lets us bring that experience to more cities, faster, and put BuyWander in front of the next wave of buyers who are done with the old returns model."
Founded in 2023 by Jordan Allen and Brock Kowalchuk, BuyWander is an auction-based marketplace that links buyers with returned and surplus goods from retailers such as Amazon, Target and Walmart.

#capital #buyers #allen

On August 6, James Hardie Industries (NYSE:JHX) reported results for the quarter ended June 30 and beat its own numbers by enough to raise guidance just three months into the fiscal year. Net sales jumped 64% year over year to $1.475 billion, adjusted EBITDA climbed 79% to $422.1 million, and both figures came in ahead of what management had originally guided investors to expect. For a company that closed a transformative acquisition less than a year earlier, that kind of overshoot forces a reassessment of the growth story ahead.
The headline growth number is inflated by the AZEK Exteriors deal folded into the base, so the more telling figure is the 12% pro forma net sales growth, which also beat original guidance. Siding & Trim, the core fiber cement business, posted organic net sales growth of 20% as North American fiber cement volumes returned to growth for the first time in several quarters. CEO Aaron Erter tied that to share gains against vinyl and other competing materials, along with programs like ColorPlus and Expanded Statement drawing more of the higher-end repair and remodel market. Adjusted EBITDA margin in that segment expanded 140 basis points to 33.5%, powered by favorable pricing, cheaper raw materials, and continued savings from the company's Hardie Manufacturing Operating System even as freight costs rose.
Management also said cost synergies from the AZEK integration are running ahead of schedule and revenue synergies are on track, evidenced by newly expanded nationwide distribution partnerships with Boise Cascade and other regional distributors. In Deck, Rail & Accessories, sell-through accelerated every month of the quarter and outpaced shipments, pulling channel inventory back to normal levels and setting up a cleaner back half of the year. Free cash flow more than doubled to $254.2 million, and the company used the cash to pay down $400 million of senior unsecured notes.
Erter was careful to frame the beat as execution rather than a healthier market, telling investors the company is "not ***** uming a housing market improvement" for the rest of fiscal 2027. Part of the quarter's strength came from an easy comparison, since channel inventory was deliberately reduced a year earlier, and management said that benefit is expected to moderate as the year goes on. Deck, Rail & Accessories net sales actually fell 5% on a pro forma basis because the company intentionally cut production to work down channel inventory, leaving the segment with an operating loss of $3.3 million for the quarter.

#Growth #sales #management

On August 6, APA Corporation (NASDAQ:APA) held its second-quarter earnings call, and one number stood out from the rest. The oil and gas producer is now holding its Permian oil production steady with four drilling rigs, half the eight it once estimated it would need. Adjusted production of 347,000 barrels of oil equivalent per day beat management's own guidance, free cash flow kept climbing, and the balance sheet is healing faster than planned. That combination is the story of the quarter.
APA raised its full-year US oil guidance to 123,000 barrels per day, up from an original 120,000, while holding its capital budget at $1.3 billion despite higher diesel and other input costs. Management also lifted its cost-savings target to $500 million in annualized run-rate savings by year-end, up from the $450 million goal it set at the start of the year.
That flexibility is showing up in cash flow. Free cash flow hit $738 million in the second quarter, pushing the first half of 2026 past $1.2 billion, which topped what APA generated in each of the past three full years. The company returned $189 million of that to shareholders through dividends and the repurchase of 2.8 million shares at an average price of $35.26, continuing a streak of returning at least 60% of free cash flow to investors every year since 2021.
The balance sheet is moving just as fast. Net debt stood at $3.3 billion at quarter-end after APA repaid $752 million of bonds in the first half, including $673 million in the second quarter alone, cutting total debt by $2.3 billion since the end of 2024 and lowering annualized interest expense by roughly $175 million. Management now expects to hit its $3 billion net debt target in 2027, well ahead of the three- to four-year window it laid out when the goal was first announced.
Further out, APA is building option value beyond its core Permian and Egypt ****** ets. It agreed to acquire Savant Alaska for $70 million, picking up an airstrip, a dock, and a pipeline connection into the Trans Alaska system to support two exploration wells planned for 2027. In Uruguay, ENI signed on as a partner in Block 6, funding a significant share of the first exploration well while APA keeps 60% ownership. In Suriname, the GranMorgu project remains on budget for first oil in mid-2028.

#billion

Interested in Toronto Dominion Bank (The)? Here are five stocks we like better.
TD plans to open 100 U.S. branches by the end of 2028, focusing on strengthening its presence in major Northeast markets while expanding in Florida and the Carolinas, subject to regulatory approval.
The bank's anti-money-laundering remediation remains ongoing: fiscal 2026 costs rose to $550 million, and new controls must still be validated by internal and external reviewers before regulatory relief.
TD is targeting C$750 million in structural U.S. cost savings to fund growth, while expanding AI use in technology, AML monitoring and customer service; its U.S. business also returned to loan growth and posted a 3.47% third-quarter net interest margin.
If Boeing Ramps Up Production, These Suppliers May Win Big

#regulatory

Guardian Metal Resources PLC (NYSEAMERICAN:GMTL) reported its first Good Hope drilling results on September 14, adding exploration potential to the Pilot Mountain tungsten project in Nevada. Hole GH26-01 returned a 12.95-meter downhole interval grading 0.79% tungsten trioxide, or WO3, starting at 12.19 meters. GH26-02 intersected 13.11 meters at 0.42% WO3 from 2.13 meters.
The holes were twinned, with GH26-02 redrilling the upper portion where core had not been recovered. Good Hope and the separate Tremor discovery remain outside the resource base supporting the existing pre-feasibility study. The investment question is whether additional mineralization can improve project returns without slowing development.
Shallow mineralization offers a potential route to additional feed that could be accessible early in a future mining sequence. Good Hope sits approximately 1.1 to 1.3 kilometers from the existing resource areas, making its possible integration worth evaluating alongside the planned operation.
The June pre-feasibility study models an eight-year open-pit operation based on Desert Scheelite and Garnet. If further work establishes economic resources at Good Hope or Tremor, additional feed could extend that operating life or improve the sequence in which material reaches the processing plant.
For Guardian Metal Resources PLC (NYSEAMERICAN:GMTL), the potential benefit is better use of infrastructure already contemplated for Pilot Mountain. That would depend on recoverable metal, processing compatibility, and the additional capital required to bring the new zones into production.

#hope #resources #guardian

Aristotle International Equity Fund, sub-advised by Aristotle Capital Management, LLC, released its second-quarter 2026 investor letter. The letter can be downloaded here. Global equity markets reached record highs in Q2, with the MSCI ACWI Index rising 14.93%, while global fixed income grew modestly by 0.87%. Geopolitical tensions, particularly in the Middle East, affected energy markets and investor sentiment, highlighting volatility and fragility in global supply. Central banks reacted variably to inflationary pressures, with the ECB raising rates amidst concerns of stagflation, while the Fed and Bank of England held rates steady. Despite economic challenges, robust earnings continued in Europe and Asia, driven by AI infrastructure demand. The Aristotle International Equity Fund (Class I-2) recorded an 8.40% return in the quarter, underperforming both the MSCI EAFE Index, which returned 10.82%, and the MSCI ACWI ex USA Index, which returned 14.49%. Going forward, the fund remains focused on quality investments as geopolitical and macroeconomic complexities make forecasting returns challenging. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Aristotle International Equity Fund highlighted Unilever PLC (NYSE:UL). Unilever PLC (NYSE:UL) is a British consumer goods giant, that sell products across food, homecare, beauty, and personal care categories. On September 17, 2026, Unilever PLC (NYSE:UL) closed at $62.22 per share. Over the past month, Unilever PLC (NYSE:UL) declined 2.99%, but its shares are down 5.09% over the past year. Unilever PLC (NYSE:UL) has a market capitalization of $133.98 billion, and its stock has traded within a 52-week range of $54.75 to $74.98.
Aristotle International Equity Fund stated the following regarding Unilever PLC (NYSE:UL) in its Q2 2026 investor letter:
"We first invested in Unilever PLC (NYSE:UL), the global consumer staples company, in the second quarter of 2013. We have long been attracted to the company's broad portfolio of leading personal care and food brands (such as Dove, Knorr and Axe), global scale, significant emerging markets exposure and strong position across everyday use categories. Over our more than decade-long holding period, Unilever strengthened and simplified its portfolio, divesting lower-growth food ***** ets, improving efficiency, increasing focus behind its largest brands and shifting the business toward faster-growing, higher-margin beauty, wellbeing, personal care and home care categories. More recently, the separation of the ice cream business and continued reshaping of the food portfolio have further narrowed Unilever's strategic focus. While we continue to view the remaining Unilever franchise as high quality, we believe the more compelling opportunity now resides in the independent ice cream business, where dedicated management and a category-specific strategy should provide a clearer pa

Fenimore ***** et Management, an investment management company, released its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time highs, though the energy sector declined. Continued earnings growth, especially among AI-related investments, supported the rally. Technology, particularly semiconductors, led performance as demand for AI infrastructure surged. Despite macroeconomic uncertainties and interest rate influences, Fenimore remains committed to investing in high-quality businesses. The Fenimore Small Cap Strategy returned 9.51% in the quarter, lagging the Russell 2000 Index's 21.49% gain. The underperformance was largely driven by avoiding lower-quality tech stocks linked to data center expansions. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Fenimore ***** et Management highlighted Ryan Specialty Holdings, Inc. (NYSE:RYAN). Ryan Specialty Holdings, Inc. (NYSE:RYAN) is a specialty insurance services company that provides distribution, underwriting, product development, administration, and risk management services. On September 17, 2026, Ryan Specialty Holdings, Inc. (NYSE:RYAN) closed at $40.03 per share. The one-month return of Ryan Specialty Holdings, Inc. (NYSE:RYAN) was -8.32%, and its shares lost 25.53% over the past 52 weeks. Ryan Specialty Holdings, Inc. (NYSE:RYAN) has a market capitalization of $10.15 billion.
Fenimore ***** et Management stated the following regarding Ryan Specialty Holdings, Inc. (NYSE:RYAN) in its Q2 2026 investor letter:
"We initiated a position in Ryan Specialty Holdings, Inc. (NYSE:RYAN), which we had previously owned after its initial public offering. The insurance industry has seen softness in rates. While RYAN's model differs from traditional retail brokerage, the company released results citing a volatile environment which led to a decrease in their earnings outlook for the year. We're encouraged by the business's long-term prospects and, in our opinion, its legendary leader Pat Ryan. He is also purchasing shares of RYAN's stock during this weakness."
Ryan Specialty Holdings, Inc. (NYSE:RYAN) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 32 hedge fund portfolios held Ryan Specialty Holdings, Inc. (NYSE:RYAN) at the end of the second quarter, compared to 35 in the previous quarter. While we acknowledge the potential of Ryan Specialty Holdings, Inc. (NYSE:RYAN) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

The Williams Companies, Inc. (NYSE:WMB) lost a key New Jersey water-quality certification for Northeast Supply Enhancement, or NESE, after a September 8 federal appeals court ruling reported by Reuters on September 9. The Third Circuit vacated the certification and returned the matter to state regulators. The Williams Companies, Inc. (NYSE:WMB) said that, at this time, it did not expect the ruling to adversely affect construction or the anticipated in-service timeline.
The project, which Reuters described as costing approximately $1 billion, expands the existing Transco network through Pennsylvania, New Jersey and New York. The Williams Companies, Inc. (NYSE:WMB) continues to target fourth-quarter 2027 service. The investment question is whether the permit review can be resolved quickly enough to protect both that schedule and the economics of the investment.
The commercial rationale rests on delivering additional gas into a constrained market. The Williams Companies, Inc. (NYSE:WMB) says demand continues to grow in areas including Brooklyn, Queens, Staten Island and Long Island. Planned capacity of approximately 400,000 dekatherms per day would expand the system's ability to serve those markets.
NESE also builds on existing infrastructure. The Williams Companies, Inc. (NYSE:WMB) plans pipeline loops, compressor work, and connections to the Transco system. Those connections give the added capacity access to an established transportation network and regional delivery points, although substantial construction remains necessary.
The remand leaves a route for reconsideration by New Jersey regulators. For The Williams Companies, Inc. (NYSE:WMB), the favorable scenario is a replacement certification that addresses the court's findings without requiring substantial redesign or disrupting the construction sequence.

#williams #NYSE #jersey #construction

Netflix (NFLX) has fallen about 35% over the past year, while the S&P 500 returned about 17%. The complaint is simple. Sales growth is slowing, and management will not show the quality metrics it leans on. That case misses the engine under per-share earnings, a wider margin, and a shrinking share count.
Why Are ***** ysts Pressing Netflix On Its Slowing Top Line?
Management guided revenue growth of 11% excluding currency for the third quarter of 2026, below the second quarter's 12% on the same basis. The CFO put part of that step down to a back-half-weighted year-ago comparison. ***** ysts have also pressed on viewing hours per member, which they say has softened.
The shares trade near $78, about 63% of their 52-week high. At that price the market appears to be paying for a mature business. The buy case has to rest on something other than the top line.
How Do Netflix's Earnings Grow Faster Than Its Sales?

#sales

Brace for minor market tremors now that the Fed has hiked interest rates by 0.25%.
Although if history holds up, any losses could prove short-lived.

The S&P 500 (^GSPC) has declined by an average of 4.0% over the six weeks following the first Fed rate hike of a cycle across seven such episodes since 1988, per new ****** ysis from strategists at The Kobeissi Letter.

Stocks recovered all of those losses over the next five to six weeks on average.

In the six months following the first interest rate hike, the S&P 500 returned 4% on average. After 12 months, the S&P 500's average gain tallied 9%. Positive returns have occurred in every episode except 2022 over the 12 months.

"Fed rate hikes have historically been great buying opportunities," the strategists added.
Read more: Follow live coverage of the Fed meeting
The decision by the Fed to lift rates comes as sticky inflation readings — from the CPI to PPI — and rising energy costs force central bankers back into tightening mode. The rate hike marks the central bank's first interest rate increase since July 2023.
Investors are also focused on the updated economic projections and the Fed's "dot plot" to gauge future moves on rates — said dot plot didn't rule out one more hike this year. A hawkish dot plot as was received and follow up commentary from Fed Chairman Kevin Warsh could further elevate borrowing costs and pressure stocks initially around the world.

#rate #hike #first #plot

Caterpillar (CAT) trades around $780. The market puts roughly a two-in-three chance that the stock finishes somewhere between about $525 and about $1,170 a year from now. That is not a forecast of direction. It is the size of the swing a holder is already carrying, and Caterpillar's own record says it is no exaggeration.
Measured from around $780, the floor of that range sits roughly a third below today's price and the ceiling close to half again above it. The extra room on the upside is arithmetic, not optimism. A stock cannot fall below zero and can rise without limit, so the upper end is always the longer one. There is also roughly a one-in-six chance of finishing above the band, and the same chance of finishing below it.
A third of the money in the position can go, and the band's low end is not the worst case. The same market pricing that drop is pricing a larger gain on the other side. The size of your position decides how much of that drop, or that gain, you actually feel.
None of that width is theoretical here. Caterpillar returned 83% over the past twelve months, against about 17% for the S&P 500, and it still trades about 26% below its 52-week high. Both of those belong to the same year. A stock that can do both is the kind an options market prices this wide.
Implied volatility of 39.9% is running level with the 40.0% the stock has actually delivered over the trailing year. The market is quoting the recent past forward rather than charging extra for fear. What could make the year ahead different sits inside the business.

#market #below #chance #around

PepsiCo (PEP) has gone nowhere for a year, down 1.8% over the past twelve months while the S&P 500 returned 16.6%. At about $135 a share it trades at 17.7 times earnings, against an S&P 500 median of 22.5. A big cash generator priced below the market is what value buyers hunt for, so is this discount impatience or a verdict?
PepsiCo sells snacks and drinks everywhere consumer staples get sold: grocery aisles, convenience and gas stations, and the away-from-home locations it keeps adding. That reach turns into cash: free cash flow over the trailing twelve months was $9.28 billion, a 5.0% yield.
None of the recent numbers look like a business in trouble. Revenue over the trailing twelve months grew 5.6%, and the operating margin is holding at 15.0% against an S&P 500 median of 18.6%. Management says global volumes grew in both foods and beverages in the first half of 2026, the fastest growth in volume since 2022.
Widen the window and the picture changes. PepsiCo's revenue grew 5.6% over the trailing twelve months against an S&P 500 median of 8.3%, and its three-year average is just 2.5% a year. The trailing twelve months ran hotter, but one window is not a pace, and the pace is what the market pays for.
The company lowered prices in the U.S. early in 2026 to get volume moving. Management says salty snacks went from falling volume to rising volume and PepsiCo gained share, but volume in the second quarter of 2026 fell short of what it expected, which it blames on a consumer hurt by higher gas prices and on delays executing the price investment at some customers. None of this is lost on the market: it is pricing a company that grows slowly and has just spent money trying to grow faster. The problem sits in North America, while the international business stayed strong.

#months #trailing

On August 4, Westlake Corporation (NYSE:WLK) reported second-quarter results that erased two consecutive quarterly losses in a single swing. Net income landed at $260 million, or $2.01 per share, compared with a $169 million loss just three months earlier and a $142 million loss a year ago. EBITDA nearly tripled from the second quarter of 2025. The numbers mark a sharp reversal for a company whose chemicals business had been bleeding red ink.
The turnaround centers on Performance and Essential Materials, the segment that makes chlorovinyls and other basic chemicals. PEM swung from a $318 million operating loss in the second quarter of 2025 to $185 million in income this quarter, while EBITDA excluding identified items jumped from a 3% margin to 21%. The driver was pricing: average sales prices across PEM rose 14% year over year, more than offsetting a 3% price decline in the Housing and Infrastructure Products segment. Combined with a 7% increase in companywide sales volume, excluding the effects of plant shutdowns and an acquisition, the pricing recovery pushed companywide EBITDA to $679 million from $210 million a year earlier.
Westlake is also working the balance sheet alongside the market recovery. The company reduced debt by $500 million during the quarter and returned $99 million to shareholders through dividends and share repurchases. Management says its three-pillar profitability improvement plan remains on track to deliver a $600 million operating income benefit, a target that, if it holds, would layer structural cost savings on top of whatever the market gives back in pricing.
Not every part of the story improved together. Housing and Infrastructure Products, the segment tied to home construction and building products, saw its EBITDA margin slip to 22% from 24% a year earlier, even as volume rose 6% excluding the ACI acquisition. Average sales prices in that segment fell 3% year over year, a sign that pricing power in housing products has softened even as the company sells more of it.
The improvement in the core chemicals business also leans heavily on price rather than volume. PEM's turnaround came from a 14% jump in average sales price, a figure that can move in either direction with commodity cycles. The first quarter of 2026 was a reminder of how quickly conditions shift: Westlake posted a $169 million net loss just three months before this result, weighed down by $85 million in identified items, including a $67 million charge to settle litigation over PVC pipe and fittings and $18 million tied to facility shutdowns. A year earlier, in the second quarter of 2025, the company absorbed another $130 million in shutdown-related charges. Restructuring and legal charges showed up in two of the last three reported quarters.

#million #year #quarter #loss

Parnassus Investments, an investment management company, released the "Parnassus Growth Equity Fund" second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index's 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services and Financials holdings detracted. For the year-to-date period, the Fund returned 6.17% (net of fees), outperforming the Russell 1000 Growth's 5.33%. The firm remains constructively bullish on U.S. equities and continues to be selective, valuation-sensitive, and focused on disruptive growth opportunities through active stock selection. Growth stocks advanced during the second quarter, as the Russell 1000 Growth Index generated strong double-digit returns driven by increased confidence in the durability of the ongoing artificial intelligence (AI) infrastructure build-out. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Parnassus Growth Equity Fund highlighted Sandisk Corporation (NASDAQ:SNDK) as a newly added position. Sandisk Corporation (NASDAQ:SNDK) develops, manufactures, and sells data storage devices and solutions using NAND flash technology in the United States and internationally. On September 15, 2026, Sandisk Corporation (NASDAQ:SNDK) closed at $1,530.90 per share. Over the past month, Sandisk Corporation (NASDAQ:SNDK) declined 2.32%, but its shares are up 1,530.74% over the past year. Sandisk Corporation (NASDAQ:SNDK) has a market capitalization of $224.15 billion, and its stock has traded within a 52-week range of $90.22 to $2,354.39.
Parnassus Growth Equity Fund stated the following regarding Sandisk Corporation (NASDAQ:SNDK) in its Q2 2026 investor letter:
"Other positions added during the quarter included Sandisk Corporation (NASDAQ:SNDK), a leader in flash memory solutions; Comfort Systems, a mechanical, electrical and plumbing contractor. Sandisk makes NAND flash memory, which is seeing a surge in demand from data centers and AI workloads. While NAND remains cyclical, we believe the combination of accelerating AI-driven storage demand and constrained supply provides an attractive opportunity to participate in the current upcycle."
Sandisk Corporation (NASDAQ:SNDK) is on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 128 hedge fund portfolios held Sandisk Corporation (NASDAQ:SNDK) at the end of the second quarter which was 114 in the previous quarter. While we acknowledge the potential of Sandisk Corporation (NASDAQ:SNDK) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our fre

Alluvium ******* et Management, an ******* et management company, released its "Conventum – Alluvium Global Fund" second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined 1.4% in EUR terms, 2.2% in USD terms, and 3.9% in AUD terms. Portfolio results were mixed, with Alphabet benefiting from strong Cloud growth, while Robert Half, H&R Block, and other holdings posted solid gains. However, cable businesses and several healthcare and consumer holdings weighed on performance. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Conventum – Alluvium Global Fund highlighted McKesson Corporation (NYSE:MCK). McKesson Corporation (NYSE:MCK) is a leading healthcare services company headquartered in Irving, Texas. On September 15, 2026, McKesson Corporation (NYSE:MCK) closed at $899.56 per share. Over the past month. McKesson Corporation (NYSE:MCK) returned 5.37% and its shares gained 29.95% over the past 52 weeks. McKesson Corporation (NYSE:MCK) has a market capitalization of $106.21 billion, and its stock has traded with a range of $687.68 and $999.00.
Conventum – Alluvium Global Fund stated the following regarding McKesson Corporation (NYSE:MCK) in its Q2 2026 investor letter:
"Our two healthcare companies had a poor quarter (in terms of share price performance, not business fundamentals). McKesson Corporation (NYSE:MCK), the drug distributor (down 12.6%), reported its full year results which were perfectly in-line with our expectations. Management provided strong guidance for its next year's earnings, and reiterated its 13%-16% long term growth expectations. After feeding the numbers through our model, our valuation increased by 18%, and with the share price trading below it, we bought a little more such that it accounts for 6.8% of the Fund."
McKesson Corporation (NYSE:MCK) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 77 hedge fund portfolios held McKesson Corporation (NYSE:MCK) at the end of the second quarter which was 73 in the previous quarter. While we acknowledge the potential of McKesson Corporation (NYSE:MCK) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

#mckesson #alluvium #global